RecruitingPhase 3NCT07225504
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
Sponsor: Novartis Pharmaceuticals
Bethesda, MD · Frederick, MD · +41 more sites
1 recruiting multiple sclerosis studies with a site in Frederick, MD.
Sponsor: Novartis Pharmaceuticals
Bethesda, MD · Frederick, MD · +41 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.